Skip to main content

Spasmodic Torticollis

2
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

AbbVie
AbbVieNORTH CHICAGO, IL
2 programs
2
botulinum toxin type APhase 41 trial
botulinum toxin type APhase 41 trial
Active Trials
NCT00432341Terminated54Est. Jun 2009
NCT00528541Completed145Est. Sep 2009
Eisai
EisaiChina - Liaoning
1 program
E2014PHASE_21 trial
Active Trials
NCT00280384Completed48

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AbbViebotulinum toxin type A
AbbViebotulinum toxin type A
EisaiE2014

Clinical Trials (3)

Total enrollment: 247 patients across 3 trials

NCT00528541AbbViebotulinum toxin type A

Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia

Start: Sep 2007Est. completion: Sep 2009145 patients
Phase 4Completed
NCT00432341AbbViebotulinum toxin type A

Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia

Start: Jun 2007Est. completion: Jun 200954 patients
Phase 4Terminated
NCT00280384EisaiE2014

An Electrophysiological Study Of E2014 In Healthy Adult Male Japanese And Caucasian Subjects

Start: Jan 200648 patients
Phase 2Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.